‘Dire’ new data highlights RHD challenge Figures released by the AIHW illustrate the huge task in tackling rheumatic heart disease, which the Government has committed to eradicating by 2031.
Australia needs a modern approach to assessing heart attack risk CT scanning of the heart has changed the way coronary artery disease risk can be assessed, writes cardiologist Professor Girish Dwivedi.
Preventable risk factors in childhood linked with midlife CVD Five childhood risk factors, individually or combined, have been identified as predictors of fatal and non-fatal cardiovascular events in adulthood.
Which diseases prompt the most spending in Australia? A new analysis published by the AIHW has ranked the spending per case of each disease in Australia for the first time.
Have the benefits of statins been overstated? Researcher Paula Byrne writes on what she and her colleagues learned from a meta-analysis of 21 clinical trials involving 140,000 patients.
Why are Aboriginal Australians still dying from an entirely preventable disease? An AJGP editorial last year highlighted the abject failure in closing the gap for rheumatic heart disease. Since then, the divide has widened further still.
Controversial Alzheimer’s drug under TGA review ‘should not be approved’ Patients will be put at risk and taxpayers will face a significant economic burden if aducanumab receives regulatory approval, experts say.
Study links mental disorders early in life to dementia Mental health disorders are often an underappreciated category of modifiable risk factors for dementia, new research suggests.
Study finds statin intolerance overestimated and overdiagnosed Fewer than 10% of patients prescribed cholesterol-lowering drugs experience side effects, according to the world’s largest study on statin intolerance.
GPs to face ongoing COVID sequelae for ‘years’ A third of older adults who contract COVID-19 develop new health conditions, researchers have found, with primary care likely to bear the brunt.